Legal Affairs
Silo Pharma’s SP-26 Ketamine Implant Meets All Endpoints in Preclinical Fibromyalgia Study
LOS ANGELES- Silo Pharma Inc. a developmental-stage biopharmaceutical company, announced that its investigational ketamine implant, SP-26, met all primary endpoints in a preclinical study targeting fibromyalgia. The study, conducted in minipigs, assessed the implant's safety, ...
Tilray Medical Introduces Good Supply Cannabis Brand to German Market
LOS ANGELES- Tilray Medical, a division of Tilray Brands Inc has launched its Canadian cannabis brand, Good Supply, in Germany. This expansion aims to provide German medical cannabis patients with access to a range of ...
MariMed Reports Q1 2025 Financial Results
LOS ANGELES- MariMed Inc. a multi-state cannabis operator, reported its financial results for the first quarter ended March 31, 2025. Financial Overview Revenue: $38.0 million, a slight increase from $37.9 million in Q1 2024. Gross ...
SNDL Reports Q1 2025 Earnings
LOS ANGELES- SNDL Inc. announced its financial and operational results for the first quarter ended March 31, 2025. The company reported net revenue of CAD $204.9 million, a 3.6% increase compared to the same period ...
Cybin CEO to Discuss Medical Innovation at Milken Institute Global Conference
LOS ANGELES- Cybin Inc. a neuropsychiatry company, announced that its Chief Executive Officer, Doug Drysdale, will participate in a panel discussion at the 28th Annual Milken Institute Global Conference. The panel, titled "The Global Landscape ...
Regulatory Advances Propel Global Medical Cannabis Market Growth
LOS ANGELES- The global medical cannabis market is experiencing significant growth, driven by regulatory reforms and increased acceptance of cannabis-based therapies. According to the "Medical Marijuana - Global Strategic Business Report 2025," the market was ...
Federal Inaction on Cannabis Exports May Cost U.S. Economy $10 Billion Annually
LOS ANGELES- The United States' federal stance on cannabis exports is potentially costing the economy up to $10 billion each year, according to industry analyses. While domestic cannabis sales are projected to reach $35.3 billion ...
Silo Pharma’s SP-26 Ketamine Implant Meets All Endpoints in Preclinical Fibromyalgia Study
LOS ANGELES- Silo Pharma Inc. a developmental-stage biopharmaceutical company, announced that its investigational ketamine implant, SP-26, met all primary endpoints in a preclinical study targeting fibromyalgia. The study, conducted in minipigs, assessed the implant's safety, ...
Tilray Medical Introduces Good Supply Cannabis Brand to German Market
LOS ANGELES- Tilray Medical, a division of Tilray Brands Inc has launched its Canadian cannabis brand, Good Supply, in Germany. This expansion aims to provide German medical cannabis patients with access to a range of ...
MariMed Reports Q1 2025 Financial Results
LOS ANGELES- MariMed Inc. a multi-state cannabis operator, reported its financial results for the first quarter ended March 31, 2025. Financial Overview Revenue: $38.0 million, a slight increase from $37.9 million in Q1 2024. Gross ...
Florida Supreme Court to Decide Fate of Cannabis Legalization
LOS ANGELES- The Florida Supreme Court is set to make a pivotal decision regarding the appearance of an adult-use cannabis legalization amendment on the November ballot, according to ClickOrlando. This determination follows a challenge by ...
Organigram Announces Investment in Open Book Extracts
NEW YORK- Organigram Holdings, a Canadian cannabis company, announced a $2 million investment in North Carolina-based Open Book Extracts. This move signifies Organigram's entry into the U.S. cannabis market, facilitated by an investment from British ...
Algernon Pharmaceuticals Advances Research Program
LOS ANGELES – In a significant move that underscores its commitment to innovative medical research, Algernon Pharmaceuticals Inc. announced its decision to prioritize its AP-188 ("N,N-Dimethyltryptamine" or "DMT") stroke research program. This announcement follows the ...
Germany Ushers in a New Era with Adult-Use Cannabis Legalization
BERLIN- As the clock struck midnight in Germany, transitioning from March 31st to April 1st, the nation embraced a historic shift in its drug policy landscape. Germany’s new adult-use cannabis legalization law, known as the ...
Colombia’s Medical Cannabis Exports Surge to $10.8 Million Amid Regulatory Enhancements
BOGOTA- In a notable advancement for Colombia's burgeoning medical cannabis industry, exports have seen a significant rise, reaching $10.8 million in 2023, as reported by ProColombia, a key government agency dedicated to fostering nontraditional Colombian ...
Glass House Brands Report Revenue and Profits
LOS ANGELES- In a notable financial turnaround, Glass House Brands, a California-based cannabis producer and retailer, reported significant growth in its fourth-quarter earnings, leading to a record revenue of $160.8 million for the fiscal year ...
ICER Raises Concerns Over MDMA-Assisted Psychotherapy for PTSD
LOS ANGELES- The Institute for Clinical and Economic Review (ICER) has recently highlighted significant concerns regarding the clinical evidence behind MDMA-assisted psychotherapy (MDMA-AP) for post-traumatic stress disorder (PTSD), according to a draft evidence report. This ...
Psilera Strengthens Board with Neuroscience
TAMPA –Psilera, a biotechnology company specializing in novel treatments for complex neurological disorders, has announced the addition of Dr. Magali Haas, M.D., Ph.D., to its Board of Directors. Dr. Haas, with an illustrious career spanning ...
Ayr Wellness Expands Florida Investment with Increased Mortgage on Cultivation Facility
LOS ANGELES- In a strategic move to bolster its presence in the burgeoning Florida cannabis market, Ayr Wellness, a prominent multistate operator, has announced an $8.4 million increase in the mortgage for its Gainesville cultivation ...
Colorado Cannabis Cultivators Granted Expanded Access to New Genetics
NEW YORK- In a significant legislative update, Colorado's cannabis cultivators are set to benefit from an expanded array of genetic resources, thanks to the enactment of Senate Bill 23-271 in January. This move, part of ...
Virginia Governor Vetoes Cannabis Legalization Bill
LOS ANGELES- In a decisive move that prolongs the status quo, Virginia Governor Glenn Youngkin has vetoed a bill aimed at legalizing the sale of adult-use cannabis in the state, citing concerns over public health ...
High Tide Acquires Premium Cannabis Brand Queen of Bud
LOS ANGELES- In a strategic move High Tide Inc. has officially completed its acquisition of the esteemed Queen of Bud brand, including its intellectual property, trademarks, and other valuable assets. This acquisition, announced on March ...
Cannabis Legislation at a Crossroads: Florida and Virginia Poised for Policy Shifts
LOS ANGELES- In a significant moment for cannabis policy in the United States, Florida and Virginia stand on the precipice of joining the expanding roster of states with legal cannabis markets. Despite facing distinct legislative ...
Colorado’s Cannabis Cultivation Landscape Evolves with New Genetic Sourcing Laws
LOS ANGELES- In a significant development for Colorado's cannabis industry, Senate Bill 23-271, effective since January, has introduced new regulations allowing cultivators to source genetics from a broader array of entities. This legislative shift aims ...
Optimi Health Corp. Expands Its Global Reach with MDMA Supply Agreement to Israeli Research Institute
LOS ANGELES – In a landmark move for psychedelic medicine, Optimi Health Corp., a preeminent manufacturer of psychedelics licensed by Health Canada, has announced a groundbreaking international supply agreement with The Institute for Psychedelic Research ...
Knowledge is Power: Unlock the Secrets to Success in the Ever-Evolving Cannabis Industry: Introducing CannabizTeam’s Comprehensive Salary Guide!
NEW YORK — CannabizTeam Worldwide, the premier executive search and staffing firm specializing in cannabis & wellness markets, proudly presents the eagerly-awaited 2024 Cannabis Industry Salary Guide. As the sixth installment of our national report, ...
Cannabis Industry Moguls Gather for Benzinga Cannabis Capital Conference
More than 100 CEOs and 200 Investors Confirmed for Cannabis Investment & Branding Conference on April 16th at The Diplomat Beach Resort in Hollywood, FL. Boris Jordan, executive chairman of Curaleaf, to Deliver Keynote Speech. HOLLYWOOD, Fla.,-- The Benzinga Cannabis ...
Mexico’s President Asserts Sovereignty in Drug Cartel Policy
LOS ANGELES- In a firm rebuff to external pressures, Mexican President Andrés Manuel López Obrador declared last week that Mexico will not engage in combative actions against drug cartels at the behest of the United ...
Amazon’s Hemp Product Dilemma: Undeclared CBD, Mislabeling, and Policy Contradictions
LOS ANGELES- A recent study conducted by CBD Oracle has shed light on the problematic state of hemp product listings on Amazon, unveiling a landscape of mislabeled items, undeclared cannabinoids, and outright policy violations. Despite ...
New York Takes Bold Steps to Support Cannabis Cultivators
LOS ANGELES- In a significant move to bolster the burgeoning adult-use cannabis industry, the New York State Cannabis Control Board (CCB) has announced a series of initiatives aimed at aiding struggling farmers and expediting the ...
Bulls Take Charge: The Green Rush Revival in the Cannabis Market
NEW YORK- As the cannabis market flourishes, several companies have made significant strides, contributing to the sector's overall bullish sentiment, beyond the widely recognized giants. Focusing on a fresh set of companies, let's explore some ...
U.S. Legal Cannabis Market Forecasted to Surpass $31 Billion in Sales in 2024
LOS ANGELES- In a notable advancement for the cannabis industry, legal sales in the United States are forecasted to exceed $31 billion this year, according to an economic forecast from Whitney Economics, a consultancy specializing ...
PharmAla Biotech and Cortexa Supply GMP Psilocybin for Therapeutic Use in Australia
LOS ANGELES- PharmAla Biotech Holdings Inc., in collaboration with Cortexa Pty. Ltd., has achieved supplying Good Manufacturing Practice (GMP) Psilocybin for therapeutic use to a patient under the Australian authorized prescriber scheme, marking what the ...
Utah to Launch Psilocybin and MDMA Pilot Program for Behavioral Health Treatment
NEW YORK-Utah is set to introduce a pioneering pilot program that will allow select hospitals to administer psilocybin and MDMA to patients for behavioral health treatment starting in May, after Governor Spencer Cox opted to ...
Massachusetts Considers Legalizing Therapeutic Psychedelics
LOS ANGELES- Last week, the Massachusetts legislature's Special Joint Committee on Initiative Petitions convened a hearing to deliberate on a proposed initiative aiming to legalize the therapeutic use of natural psychedelics. The measure, which seeks ...
